Accessibility Menu
SSY Group logo

SSY Group(SEHK) 2005

Market CapHK$7.95BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+1,181%
5 Year-42%
1 Year-6%
1 Month+14%
HK$2.71
+0.18%
+0.00Today
SSY Group last closing stock price
MetricPriceDate
Last closeHKD 2.712026-09-01
SSY Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+7.54%HKD 2.522026-08-25
1 month+13.87%HKD 2.382026-07-31
3 month+17.32%HKD 2.312026-06-03
Year to date-4.24%HKD 2.832025-12-31
1 year-5.9%HKD 2.882025-09-01
3 year-35.01%HKD 4.172023-08-31
5 year-42.22%HKD 4.692021-09-02
Since inception+1,180.95%HKD 0.212005-12-20

SSY Group Financials at a Glance

Market Cap

HK$7.95BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

HK$8.96B

Net Income (TTM)

HK$1.17B

EPS (TTM)

HK$0.17

P/E Ratio

15.48

Dividend

HK$0.08

Beta (Volatility)

-0.03 (Low)

Price

HK$2.71

Volume

170,000

Open

HK$2.70

Previous Close

HK$2.71

Daily Range

HK$2.70 - HK$2.73

52-Week Range

HK$2.01 - HK$3.40

Estimated Earnings Date

Mar 26, 2027

2005 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SSY Group

SSY Group Limited is a prominent player in the pharmaceutical industry, focusing on the research, development, manufacturing, and distribution of a wide range of medical products. The company primarily serves hospitals and distributors in China and internationally, offering innovative intravenous infusion solutions and various pharmaceutical preparations.

Products and Services
  • Intravenous infusion solutions, including non-PVC and soft bag options
  • Small volume injections and oral preparations
  • Research and consulting services in pharmaceutical technology
Growth Outlook
  • Revenue growth of 12% year-over-year in the latest quarter
  • Expansion into international markets expected to drive future sales
  • Investment in R&D projected to enhance product offerings and market competitiveness
Financial Highlights
  • Recent quarterly revenue of 2.02 billion HKD, reflecting strong demand
  • Net income of 187 million HKD in the latest quarter, showcasing profitability
  • TTM gross profit margin of 41.56%, indicating efficient cost management
SSY Group Limited has established itself as a significant entity in the healthcare sector, with a diverse portfolio of pharmaceutical products. The company's focus on innovation and quality positions it well for future growth, particularly as it seeks to expand its reach beyond domestic markets. Recent financial performance highlights a robust revenue stream and profitability, which may attract potential investors looking for opportunities in the pharmaceutical industry. The commitment to research and development further enhances the company's potential for long-term success, making it a noteworthy consideration for those interested in the healthcare sector.
AI Generated • Aug 12, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

5,500

CEO

Ji Guang Qu

Website

www.ssygroup.com.hk

Headquarters

Hong Kong, 200021, HK

2005 Financials

Key Financial Metrics (TTM)

Gross Margin

40.03%

Operating Margin

14.79%

Net Income Margin

11.59%

Return on Equity

6.72%

Return on Capital

5.56%

Return on Assets

3.77%

Earnings Yield

6.46%

Dividend Yield

2.97%

Payout Ratio

28.91%

Stock Overview

Market Cap

HK$7.95BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.95B

Volume

170.00K

Avg. Volume

4.70M

Financials (TTM)

Gross Profit

HK$3.71B

Operating Income

HK$1.51B

EBITDA

HK$2.31B

Operating Cash Flow

HK$823.72M

Capital Expenditure

-HK$227.75M

Free Cash Flow

HK$595.97M

Cash & ST Invst.

HK$1.97B

Total Debt

HK$4.05B

SSY Group Performance Analysis

SSY Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31HKD 6,434,025,00020.1%
20232023-12-31HKD 6,463,009,0000.5%
20242024-12-31HKD 5,773,251,000-10.7%
20252025-12-31HKD 4,165,465,000-27.8%
SSY Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-27.1%
Q22025-06-30-11.8%
Q42025-12-31-6.0%
Q22026-06-3017.0%
SSY Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31HKD 0.3845.2%
20232023-12-31HKD 0.4417.7%
20242024-12-31HKD 0.36-19.1%
20252025-12-31HKD 0.16-55.2%
SSY Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-43.5%
Q22025-06-30-26.0%
Q42025-12-31-33.4%
Q22026-06-3071.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

HK$2.36B

-29.3%

Gross Profit

HK$912.08M

-50.5%

Gross Margin

38.64%

N/A

Market Cap

HK$7.95BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$1.45M

N/A

Employees

5,472

N/A

Net Income

HK$320.32M

-53.3%

EBITDA

HK$618.55M

-43.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

HK$1.97B

+22.9%

Total Debt

HK$4.05B

+12.1%

Accounts Receivable

HK$1.81B

-18.5%

Inventory

HK$1.24B

+8.5%

Long Term Debt

HK$2.19B

-19.3%

Short Term Debt

HK$1.86B

+107.4%

Return on Assets

3.77%

N/A

Return on Invested Capital

6.08%

N/A

Free Cash Flow

HK$0.00

-100.0%

Operating Cash Flow

HK$0.00

-100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 2005

What is the current price of SSY Group?

SSY Group is trading at HK$2.71 per share.

What is the 52-week range for SSY Group?

Over the past 52 weeks, SSY Group has traded between HK$2.01 and HK$3.40.

How much debt does SSY Group have?

As of the most recent reporting period, SSY Group reported total debt of HK$4.01B.

How much cash does SSY Group have on hand?

SSY Group reported HK$1.71B in cash and cash equivalents in its most recent financial results.

What is SSY Group’s dividend yield?

SSY Group currently has a dividend yield of 2.97%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services